Sector Gamma AS’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Sector Gamma AS’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-33,814	Closed	-$1.84M	–	37
2018 Q3	$1.84M	Buy	33,814 +2,214	+7%	+$151K	0.29%	30
2018 Q2	$2.62M	Sell	31,600 -15,000	-32%	-$1.16M	0.43%	30
2018 Q1	$3.1M	Sell	46,600 -5,900	-11%	-$341K	0.56%	29
2017 Q4	$2.7M	Buy	+52,500	New	+$3.77M	0.45%	32

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Sector Gamma AS's ONCE Position: Q4 2018 in Review

Sector Gamma AS sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2018, closing a stake of 33,814 shares — an estimated $1.84M sold.

Sector Gamma AS first reported a position in ONCE in Q4 2017 and held it in 4 quarters. The position peaked at $3.1M in Q1 2018. 157 funds tracked by Wall St. Rank hold ONCE as of Q4 2018.

Sector Gamma AS reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Sector Gamma AS sold 33,814 Spark Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $1.84M.
Sector Gamma AS first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 4 quarters.
Sector Gamma AS's Spark Therapeutics, Inc. Common Stock position peaked at $3.1M in Q1 2018.
157 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Sector Gamma AS's 13F filing for Q4 2018, filed 12 Feb 2019.